RB1 can also carry point mutations which are often heterozygous and have been suggested to play a less clear role in disease aggressiveness, whereas homozygous RB1 deletions have been linked to high-grade IDHmut astrocytomas and disease aggressiveness [35]. The gene discussed is RB1; the disease is astrocytoma (excluding glioblastoma).